Estimates Revisions THX Pharma

Stocks

Real-time Euronext Paris 09:33:19 2026-09-15 EDT			5-day change	1st Jan Change
3.230 ^EUR	-3.29%		-14.32%	+50.93%

09-02	THX Pharma Partnership Seeks Regulatory Clearance for Late-stage Juvenile Batten Disease Drug Trial	MT
09-01	THX Pharma Submits Regulatory Applications To Initiate Phase 3 Clinical Trial Of Batten-1 In Juvenile Batten Disease	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.
THX PHARMA	-	-
WUXI APPTEC CO., LTD.
ARGENX SE
INSMED INCORPORATED
WUXI BIOLOGICS (CAYMAN) INC.
BIONTECH SE
GENMAB A/S
PHARMAESSENTIA CORPORATION
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
SUMMIT THERAPEUTICS INC.
Average
Weighted average by Cap.